Amicus Therapeutics Inc logo

Amicus Therapeutics Inc

$ 12.27 +0.17 (+1.4%) 03:40 PM EST
P/E:
At Loss
P/B:
26.15
Market Cap:
$ 3.45B
Enterprise V:
$ 3.50B
Volume:
1.35M
Avg Vol (2M):
2.45M
Also Trade In:
Volume:
1.35M
Market Cap $:
3.45B
PE Ratio:
At Loss
Avg Vol (2-Month):
2.45M
Enterprise Value $:
3.50B
PB Ratio:
26.15
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset 0.18
Debt-to-Equity 3.4
Debt-to-EBITDA -2.12
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.37
Distress
Grey
Safe
Beneish M-Score -3.24
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 81.26
9-Day RSI 71.53
14-Day RSI 65.26
6-1 Month Momentum % 31.23
12-1 Month Momentum % -6.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.78
Quick Ratio 2.7
Cash Ratio 2.15
Days Inventory 211.45
Days Sales Outstanding 59.02
Days Payable 204.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8

Financials (Next Earnings Date:2023-02-24 Est.)

FOLD's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:FOLD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 323.291
EPS (TTM) ($) -0.92
Beta 0.55
Volatility % 64.98
14-Day RSI 65.26
14-Day ATR ($) 0.566626
20-Day SMA ($) 11.035
12-1 Month Momentum % -6.63
52-Week Range ($) 5.91 - 12.96
Shares Outstanding (Mil) 280.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amicus Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Amicus Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.